Kathy Ordoñez compensation by year
PACIFIC BIOSCIENCES OF CALIFORNIA Summary Compensation Table · all 2 fiscal years held| Component | FY2017 | FY2018 |
|---|---|---|
| Salary | $1 | $1 |
| Bonus | $0 | $170,000 |
| Stock awards | $0 | $373,953 |
| Option awards | $693,338 | $134,304 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $0 | $0 |
| Total | $693,339 | $678,258 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. DEF 14A filed April 29, 2019, accession 0001299130-19-000019, and prior-year filings. Open the filing on EDGAR.
How this page was built: the PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filed document, accession 0001299130-19-000019. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2019.
Equity holdings
unvested awards at FY2018 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 273,440 | — | $2.90 |
| Option | 69,272 | — | $2.63 |
Per the Outstanding Equity Awards at Fiscal Year-End table in PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
3 Form 4 lines since the FY2018 proxy (filed April 29, 2019)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-11-17 | Sale | — | 18,595 | $1.78 | 384,442 |
| 2026-06-03 | Grant or award derivative | — | 223,492 | $0.00 | 223,492 |
| 2025-06-04 | Grant or award derivative | — | 65,000 | $0.00 | 65,000 |
The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
PACIFIC BIOSCIENCES OF CALIFORNIA’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Michael Hunkapiller | Former President, Chief Executive Officer | $1,610,866 |
| Susan Barnes | Former Executive Vice President & Chief Financial Officer | $1,125,758 |
| Kathy Ordoñez · this page | Chief Commercial Officer and member of the Board of Directors | $678,258 |
| Michael Phillips | Former Senior Vice President of Research and Development | $616,991 |
| Kevin Corcoran | Senior Vice President of Market Development | $594,568 |
Board service
PACIFIC BIOSCIENCES OF CALIFORNIA board · FY2021–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $57,000 | — | $49,554 | $0 | $106,554 |
| FY2024 | $57,000 | $37,655 | $37,656 | — | $132,311 |
| FY2023 | $51,166 | — | $199,996 | — | $251,162 |
| FY2022 | $52,917 | — | $199,998 | — | $252,915 |
| FY2021 | $49,083 | — | $199,993 | $0 | $249,076 |
Each year as the company reported it in PACIFIC BIOSCIENCES OF CALIFORNIA's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: PACIFIC BIOSCIENCES OF CALIFORNIA pays directors a $40,000 cash retainer and $200,000 in equity. As stated in PACIFIC BIOSCIENCES OF CALIFORNIA's FY2025 proxy.
Committees
Nominating/Governance · Science and Technology (Chair)
The full PACIFIC BIOSCIENCES OF CALIFORNIA compensation record
free company briefThis page is one person within PACIFIC BIOSCIENCES OF CALIFORNIA's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the PACIFIC BIOSCIENCES OF CALIFORNIA proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PACIFIC BIOSCIENCES OF CALIFORNIA's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.